Celecoxib Suppresses NF-κB p65 (RelA) and TNFα Expression Signaling in Glioblastoma

Background: Glioblastoma (GBM) harbors significant genetic heterogeneity, high infiltrative capacity, and patterns of relapse following many therapies. The expression of nuclear factor kappa-B (NF-κB p65 (RelA)) and signaling pathways is constitutively activated in GBM through inflammatory stimulati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahsan, Hina, Malik, Shaukat Iqbal, Shah, Fawad Ali, El-Serehy, Hamed A., Ullah, Amin, Shah, Zafar Abbas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607796/
https://www.ncbi.nlm.nih.gov/pubmed/37892820
http://dx.doi.org/10.3390/jcm12206683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607796/
https://www.ncbi.nlm.nih.gov/pubmed/37892820
http://dx.doi.org/10.3390/jcm12206683

Ejemplares similares